Company profile
Kailera Therapeutics, Inc. Insider Trading
KLRAEvery SEC Form 4 insider trading filing for Kailera Therapeutics, Inc. (KLRA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002096997
- Filings
- 20
- Insiders
- 28
- Last filing
- 2026-09-07
Activity summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Nur Nicholson.
Quarterly balance
Buy and sell value by quarter, Q2 26 to Q3 26. Kailera Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $327.0M.
90 day insight
Over the last 90 days, Kailera Therapeutics, Inc. insiders bought $0 across 2 transactions with no open-market sales.
- Most active insider: Nur Nicholson with 1 transaction totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 7, 2026 | Nur Nicholson | KLRA | Award | 220,000 | — | — |
| Jul 6, 2026 | Kathleen Tregoning | KLRA | Award | 175,000 | — | — |
| Jun 9, 2026 | Ronald C Renaud JR | KLRA | Option Exercise | 38,094 | $5.25 | $200K |
| Jun 9, 2026 | Ronald C Renaud JR | KLRA | Option Exercise | 38,094 | — | — |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | KLRA | C | 17,857,143 | — | — |
43 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=KLRA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.